Henry Schein, Inc. HSIC

86.37 0.84 0.98% as of 25 Sep
Market cap
$9.5B
P/E
25.0×
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month

Henry Schein, Inc. (HSIC) EV/Sales

As of 25 September 2026, Henry Schein, Inc. (HSIC) trades at a EV/Sales of 0.9×. Over the past ten years it has ranged from 0.7× (April 2020) to 1.8× (December 2018); the current reading is higher than 28% of that period. That is above the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 0.9× 3.25%
FY2024 0.8× (12.94%)
FY2023 1.0× 2.72%
FY2022 0.9× (0.30%)
FY2021 0.9× (3.04%)
FY2020 1.0× (8.43%)
FY2019 1.1× (4.26%)
FY2018 1.1× 2.19%
FY2017 1.1× 17.17%
FY2016 0.9× (8.87%)

Quarterly

Period EV/Sales Change
Jun 2026 0.9× 8.16%
Mar 2026 0.8× (6.92%)
Dec 2025 0.9× 10.80%
Sep 2025 0.8× (9.03%)
42 more quarters

Against its own ten years

Low 0.7× High 1.8×
Ten-year median 0.9×
Current reading's percentile 28

EV/Sales against peers

Company EV/Sales
YI 111, Inc. Sponsored ADR compare 0.0×
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.2×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. 0.9×
AHG Akso Health Group Sponsored ADR compare 1.5×
FOCL FocalTherics compare 2.4×
Medical Distribution industry median 0.6×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HSIC